UNSPSC 51401603: Tiapride

This classification denotes an anti-dyskinesia agent, antipsychotic agent, and dopamine antagonist with the molecular formula C15H24N2O4S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier LAH70H9JPH, chemically known as benzamide, n-(2-(diethylamino)ethyl)-2-methoxy-5-(methylsulfonyl)- but generally known as tiapride, which bears US NIH Compound Identifier 5467. European Medicines Agency schedules Tiapride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11010MIG.

UNSPSC 51401603 Tiapride is a Commodity code that nominally covers a specific pharmaceutical product, but recent state and local procurement activity under this code shows minimal alignment with the code's stated scope. The single recent opportunity posted under this code—Seminole County, Florida's IFB60459723LAS—solicits naloxone and drug deactivation systems, not tiapride itself. State and local governments use this code infrequently, and when they do, issuing bodies appear to be county health and community services departments procuring emergency response pharmaceuticals and harm-reduction equipment rather than the antipsychotic medication the code nominally describes. The procurement landscape under 51401603 does not yet show a defined pattern of repeat buyers or consistent commodity focus; the single visible opportunity suggests county-level health authorities are the primary user when the code appears in state and local solicitations at all.

Seminole County, Florida represents the only recent documented activity, with the IFB posted June 30, 2026 and response deadline July 26, 2023 for annual delivery of 1,900 units of naloxone and 800 safe drug deactivation systems to the Seminole County Community Health Building in Sanford with quarterly shipments. The procurement follows standard county IFB procedures, requiring electronic bid submission through the county's e-Procurement Portal, drug-free workplace certification, E-Verify compliance, and fixed-fee pricing. The contract includes a two-year initial term with one-year renewal option and carries a three-month probationary termination clause. Geographic activity is limited to Florida in the recent record, and the code shows little activity depth across state and local jurisdictions—pursue this code only if your firm has direct relationships with county health procurement offices or holds prequalification on naloxone and emergency-response pharmaceutical supply contracts.